Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An in-depth analysis of antimicrobial prescription quality in 10 non-university hospitals, in southwest Germany, 2021.
Först G, Giesen R, Fink G, Sehlbrede M, Wimmesberger N, Allen R, Meyer K, Müller S, Niese H, Polk S, Reistle B, Schuhmacher C, von Ameln-Meyerhofer A, Winter K, Wirth D, Kern WV, Farin-Glattacker E, Rieg S; ID ROLL OUT Study group; Other members of the ID ROLLOUT study group. Först G, et al. Among authors: schuhmacher c. Euro Surveill. 2024 Nov;29(46):2400156. doi: 10.2807/1560-7917.ES.2024.29.46.2400156. Euro Surveill. 2024. PMID: 39544144 Free PMC article.
Prevention of incisional hernia with prophylactic onlay and sublay mesh reinforcement vs. primary suture only in midline laparotomies (PRIMA): long-term outcomes of a multicentre, double-blind, randomised controlled trial.
Van den Dop LM, Sneiders D, Yurtkap Y, Werba A, van Klaveren D, Pierik REGJM, Reim D, Timmermans L, Fortelny RH, Mihaljevic AL, Kleinrensink GJ, Tanis PJ, Lange JF, Jeekel J; PRIMA Trialist Group. Van den Dop LM, et al. Lancet Reg Health Eur. 2023 Nov 22;36:100787. doi: 10.1016/j.lanepe.2023.100787. eCollection 2024 Jan. Lancet Reg Health Eur. 2023. PMID: 38188275 Free PMC article.
Antimicrobial Stewardship with and without Infectious Diseases Specialist Services to Improve Quality-of-Care in Secondary and Tertiary Care Hospitals in Germany: Study Protocol of the ID ROLL OUT Study.
Zimmermann N, Allen R, Fink G, Först G, Kern WV, Farin-Glattacker E, Rieg S; ID ROLL OUT Study group. Zimmermann N, et al. Infect Dis Ther. 2022 Feb;11(1):617-628. doi: 10.1007/s40121-021-00552-1. Epub 2021 Nov 9. Infect Dis Ther. 2022. PMID: 34751941 Free PMC article.
Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials.
Ronellenfitsch U, Jensen K, Seide S, Kieser M, Schwarzbach M, Slanger TE, Burmeister B, Kelsen D, Niedzwiecki D, Piessen G, Schuhmacher C, Urba S, van de Velde C, Ychou M, Hofheinz R, Lorenzen S. Ronellenfitsch U, et al. Among authors: schuhmacher c. Eur J Cancer. 2019 Dec;123:101-111. doi: 10.1016/j.ejca.2019.10.001. Epub 2019 Nov 1. Eur J Cancer. 2019. PMID: 31678767 Free PMC article.
Perioperative chemotherapy with or without epidermal growth factor receptor blockade in unselected patients with locally advanced oesophagogastric adenocarcinoma: Randomized phase II study with advanced biomarker program of the German Cancer Society (AIO/CAO STO-0801).
Stahl M, Maderer A, Lordick F, Mihaljevic AL, Kanzler S, Hoehler T, Thuss-Patience P, Mönig S, Kunzmann V, Schroll S, Sandermann A, Tannapfel A, Meyer HJ, Schuhmacher C, Wilke H, Moehler M; Arbeitsgemeinschaft Internistische Onkologie (AIO) Oesophageal and Gastric Cancer Working Group and the Chirurgische Arbeitsgemeinschaft Onkologie (CAOGI/DGAV) of the German Cancer Society. Stahl M, et al. Among authors: schuhmacher c. Eur J Cancer. 2018 Apr;93:119-126. doi: 10.1016/j.ejca.2018.01.079. Epub 2018 Mar 20. Eur J Cancer. 2018. PMID: 29501977 Clinical Trial.
Prevention of incisional hernia with prophylactic onlay and sublay mesh reinforcement versus primary suture only in midline laparotomies (PRIMA): 2-year follow-up of a multicentre, double-blind, randomised controlled trial.
Jairam AP, Timmermans L, Eker HH, Pierik REGJM, van Klaveren D, Steyerberg EW, Timman R, van der Ham AC, Dawson I, Charbon JA, Schuhmacher C, Mihaljevic A, Izbicki JR, Fikatas P, Knebel P, Fortelny RH, Kleinrensink GJ, Lange JF, Jeekel HJ; PRIMA Trialist Group. Jairam AP, et al. Among authors: schuhmacher c. Lancet. 2017 Aug 5;390(10094):567-576. doi: 10.1016/S0140-6736(17)31332-6. Epub 2017 Jun 20. Lancet. 2017. PMID: 28641875 Clinical Trial.
Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs).
Ronellenfitsch U, Schwarzbach M, Hofheinz R, Kienle P, Nowak K, Kieser M, Slanger TE, Burmeister B, Kelsen D, Niedzwiecki D, Schuhmacher C, Urba S, van de Velde C, Walsh TN, Ychou M, Jensen K. Ronellenfitsch U, et al. Among authors: schuhmacher c. Eur J Surg Oncol. 2017 Aug;43(8):1550-1558. doi: 10.1016/j.ejso.2017.05.005. Epub 2017 May 18. Eur J Surg Oncol. 2017. PMID: 28551325
Different survival outcomes after curative R0-resection for Eastern Asian and European gastric cancer: Results from a propensity score matched analysis comparing a Korean and a German specialized center.
Kim YW, Joo J, Yoon HM, Eom BW, Ryu KW, Choi IJ, Kook MC, Schuhmacher C, Siewert JR, Reim D. Kim YW, et al. Among authors: schuhmacher c. Medicine (Baltimore). 2016 Jul;95(28):e4261. doi: 10.1097/MD.0000000000004261. Medicine (Baltimore). 2016. PMID: 27428238 Free PMC article.
85 results